Novel in vitro perfusion model to study the interaction between coagulation and blood-borne metastasis

Journal of Cellular Biochemistry

Volumn 96, Issue 4, 2005, Pages 700-708

  Sehgal, Lakshman R ^a,b   Wong, Jonathan ^a   He, Jie ^a   Wood, Trisha ^a   Takagi, Ippei ^a   Eldibany, Mohamed ^a   Caprini, Joseph ^a,b   Mousa, Shaker A ^c,d  

^a Evanston Northwestern Healthcare ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d Pharmaceutical Research Institute   (United States)

Author keywords

Coagulation; Metastasis; Perfusion; Vein segments

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; BLOOD; BLOOD CLOTTING; BREAST CANCER; CANCER CELL; CELL ADHESION; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SAPHENOUS VEIN; SERUM; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; THROMBOSIS; UMBILICAL CORD;

BLOOD CIRCULATION; BLOOD COAGULATION; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; FEMALE; HUMANS; NEOPLASM METASTASIS; PERFUSION; SAPHENOUS VEIN; UMBILICAL VEINS;

ANIMALIA;

EID: 27644553901     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20571     Document Type: Article

References (36)

1. Ambrus JL, Ambrus CM, Mink IB, Pickren JW. 1975a. Causes of death in cancer patients. J Med 6:61-64.
2. Ambrus JL, Ambrus CM, Pickren JW, Soldes S, Bross I. 1975b. Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis. J Med 6:433-458.
3. Baumgartner HR. 1973. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 5:167-179.
4. Bick RL. 1992. Coagulation abnormalities in malignancy: A review. Semin Thromb Hemost 18:353-372.
5. Chambers AF. 1999. The metastatic process: Basic research and clinical implications. Oncol Res 11:161-168.
6. Chambers AF, MacDonald IC, Schmidt EE, Koop S, Morris VL, Khokha R, Groom AC. 1995. Steps in tumor metastasis: New concepts from intravital videomicroscopy. Cancer Metastasis Rev 14:279-301.
7. Costantini V, De Monte P, Cazzato AO, Stabile AM, Deveglia R, Frezzato E, Paolucci MC. 1998. Systemic thrombin generation in cancer patients is correlated with extrinsic pathway activation. Blood Coagul Fibrinolysis 9:79-84.
8. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM. 2001. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98:1853-1858.
9. Friedl P. 1996. Migration of human peripheral T lymphocytes and cancer cells from primary explants in three-dimensional collagen lattices: Cell biology and molecular principles [Ph.D. thesis]. McGill University, Montreal, Canada.
10. Friedl P, Brocker EB, Zanker KS. 1998. Integrins, cell matrix interactions and cell migration strategies: Fundamental difference in leukocytes and tumor cells. Cell Adhes Commun 6:225-236.
11. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S. 1973. Platelet-tumor-cell interactions in mice: The role of platelets in the spread of malignant disease. Int J Cancer 11:704-718.
12. Gimbrone MA, Nagel T, Topper JN. 1997. Biomechanical activation: An emerging paradigm in endothelial adhesion biology. J Clin Invest 99:1809-1813.
13. Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SS, Lupu R. 2000. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines. Int J Oncol 17:629-641.
14. Hilgard P. 1973. The role of blood platelets in experimental metastases. Br J Cancer 28:429-435.
15. Honn KV, Tang DG, Crissman JD. 1992. Platelets and cancer metastasis: A casual relationship? Cancer Metastasis Rev 11:325-351.
16. Jacob MP, Badier-Commander C, Fontaine V, Benazzoug Y, Feldman L, Michel JB. 2001. Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris) 49:326-332.
17. Labadie RF, Antaki JF, Williams JL, Katyal S, Ligush J, Watkins SC, Pham SM, Borovetz HS. 1996. Pulsatile perfusion system for ex vivo investigation of biochemical pathways in intact vascular tissue. Am J Physiol 270 (2 pt 2):H760-H768.
18. Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, Mantovani A, Donati MB. 1983. Generation of procoagulant activity by mononuclear phagocytes: A possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62:271-273.
19. Moore MA. 2001. The role of chemoattraction in cancer metastases. Bioessays 23:674-676.
20. Mousa SA. 2000. Mechanisms of angiogenesis in vascular disorders: Potential therapeutic targets. In: Mousa S, Landes RG, editors. Angiogenesis inhibitors and stimulators: Potential therapeutic implications. Georgetown, TX: Landes Bioscience, pp 1-12.
21. Mousa SA. 2002. Anticoagulants in thrombosis and cancer: The missing link. Semin Thromb Hemost 28:45-52.
22. Mueller BM, Ruf W. 1998. Requirement of binding of catalytically active factor Vila in tissue factor-dependent experimental metastasis. J Clin Invest 101:1372-1378.
23. Mueller BM, Reisfeld EA, Edgington TS, Ruf W. 1992. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 89:111832-111836.
24. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. 1991. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 87:229-236.
25. Nierodzik ML, Kajumo F, Karpatkin S. 1992. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 52:3267-3272.
26. Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJ. 1996. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia. Cardiovasc Res 31:607-614.
27. Price JT, Bonovich MT, Kohn EC. 1997. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 32:175-253.
28. Rambaldi A, Alessio G, Casali B, Passerini CG, Donati MB, Mantovani A, Semeraro N. 1986. Induction of monocyte-macrophage procoagulant activity by transformed cell lines. J Immunol 136:3848-3855.
29. Rickles FR, Edwards RL, Barb C, Cronlund M. 1983. Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide A generation and tumor growth. Cancer 51:301-307.
30. Rickles FR, Levine M, Edwards RL. 1992. Hemostatic alterations in cancer patients. Cancer Met Rev 11:237-248.
31. Sack GH, Levin J, Bell W. 1977. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathologic and therapeutic features. Medicine 56:1-37.
32. Trikha M, Nakada M. 2002. Platelets and cancer: Implications for antiangiogenic therapy. Semin Thromb Hemost 28:39-44.
33. Turitto VT, Weiss HJ, Baumgartner HR. 1983. Decreased platelet adhesion on vessel segments in von Willebrand's disease: A defect in initial platelet attachment. J Lab Clin Med 102:551-564.
34. Yoda Y, Abe T. 1981. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease. Thromb Haemost 46:706-709.
35. Ziober BL, Lin CS, Kramer RH. 1996. Laminin-binding integrins in tumor progression and metastasis. Semin Cancer Biol 7:119-128.
36. Zucker S. 1999. Experimental models to identify antimetastatic drugs: Are we there yet? A position paper. Annals N Y Acad Sci 878:208-211.